DHFR and retinal detachment: They proposed that as MTX inhibits DHFR, it is only effective on the fraction of cells that are at the S phase of the cell cycle and therefore active proliferation.[21] This might explain the ineffectiveness of intravitreal injection of MTX in the reduction of PVR and subsequent retinal detachment.